Our proprietary processes have achieved commercial production of 30 monoclonal antibodies and 27 highly purified recombinant cytokines, currently sold to the scientific community worldwide.
Bulk quantity of 50 - 1000 mg are available at extremely
competitive prices.
Process development including serum-free media optimization, mid-scale
production and purification is also available. More information is available at Production of Biologics.